Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Boris Fehse

Showing results (81-90 of 207) with videos related to

Pageof 21
Sort By:
Mediators of Inflammation|April 24, 2014
5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activityThomas Stübig, Anita Badbaran, Tim Luetkens, et al.
Clinical and Experimental Medicine|July 25, 2009
Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosisUlrike Bacher, Svetlana Asenova, Anita Badbaran, et al.
Blood|October 4, 2012
SOCS3 promotes interleukin-17 expression of human T cellsKatja Kleinsteuber, Kerrin Heesch, Stefanie Schattling, et al.
Cancers|July 24, 2020
Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCRAnita Badbaran, Carolina Berger, Kristoffer Riecken, et al.
Human Gene Therapy|December 5, 2018
Consensus Statement of European Societies of Gene and Cell Therapy on the Reported Birth of Genome-Edited Babies in ChinaHildegard Büning, Uta Griesenbach, Boris Fehse, et al.
Pharmaceutics|June 24, 2022
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell TransplantationAdrin Dadkhah, Sebastian Georg Wicha, Nicolaus Kröger, et al.
Blood|February 25, 2018
The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemiaSimon Schliffke, Sophia Buhs, Sarah Bolz, et al.
Journal of Hematotherapy & Stem Cell Research|June 14, 2003
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantationNatalja Fehse, Boris Fehse, Nicolaus Kröger, et al.
Stem Cells and Development|June 3, 2016
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted MicePierre Abramowski, Susanne Krasemann, Thomas Ernst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantationFrancis Ayuk, Galina Diyachenko, Tatjana Zabelina, et al.
Pageof 21

Showing results (81-90 of 207) with videos related to

Sort By:
Pageof 21
Mediators of Inflammation|April 24, 2014
5-azacytidine promotes an inhibitory T-cell phenotype and impairs immune mediated antileukemic activityThomas Stübig, Anita Badbaran, Tim Luetkens, et al.
Clinical and Experimental Medicine|July 25, 2009
Bone marrow mesenchymal stromal cells remain of recipient origin after allogeneic SCT and do not harbor the JAK2V617F mutation in patients with myelofibrosisUlrike Bacher, Svetlana Asenova, Anita Badbaran, et al.
Blood|October 4, 2012
SOCS3 promotes interleukin-17 expression of human T cellsKatja Kleinsteuber, Kerrin Heesch, Stefanie Schattling, et al.
Cancers|July 24, 2020
Accurate In-Vivo Quantification of CD19 CAR-T Cells after Treatment with Axicabtagene Ciloleucel (Axi-Cel) and Tisagenlecleucel (Tisa-Cel) Using Digital PCRAnita Badbaran, Carolina Berger, Kristoffer Riecken, et al.
Human Gene Therapy|December 5, 2018
Consensus Statement of European Societies of Gene and Cell Therapy on the Reported Birth of Genome-Edited Babies in ChinaHildegard Büning, Uta Griesenbach, Boris Fehse, et al.
Pharmaceutics|June 24, 2022
Population Pharmacokinetics of Busulfan and Its Metabolite Sulfolane in Patients with Myelofibrosis Undergoing Hematopoietic Stem Cell TransplantationAdrin Dadkhah, Sebastian Georg Wicha, Nicolaus Kröger, et al.
Blood|February 25, 2018
The phosphotyrosine phosphatase SHP2 promotes anergy in chronic lymphocytic leukemiaSimon Schliffke, Sophia Buhs, Sarah Bolz, et al.
Journal of Hematotherapy & Stem Cell Research|June 14, 2003
Influence of anti-thymocyte globulin as part of the conditioning regimen on immune reconstitution following matched related bone marrow transplantationNatalja Fehse, Boris Fehse, Nicolaus Kröger, et al.
Stem Cells and Development|June 3, 2016
Mesenchymal Stromal/Stem Cells Do Not Ameliorate Experimental Autoimmune Encephalomyelitis and Are Not Detectable in the Central Nervous System of Transplanted MicePierre Abramowski, Susanne Krasemann, Thomas Ernst, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|July 22, 2008
Comparison of two doses of antithymocyte globulin in patients undergoing matched unrelated donor allogeneic stem cell transplantationFrancis Ayuk, Galina Diyachenko, Tatjana Zabelina, et al.
Pageof 21